trial · primary record
Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine)
Cardiac Arrest
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 65 |
| Primary completion | 2026-09-30 |
| Primary endpoint | Cumulative incidence of weaning from vasopressors at day 3 after OHCA. |
| Registry ID | NCT05817851 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:09.719Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05817851
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.